Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Argenx declares Phase 3 win for Vyvgart Hytrulo in autoimmune myositis

Argenx said Monday that Vyvgart Hytrulo passed a late-stage test in a family of rare autoimmune diseases, even though the drug missed the mark in a key patient subgroup. The subcutaneous drug

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at endpoints.news →

More in Health & Medicine

What to expect at inaugural Kenya Health Summit 2026

Health CS Aden Duale says the summit will provide a platform to present the government’s achievements in health financing, digital health, healthcare workforce, primary healthcare and specialised services. The post What to expect at inaugural Kenya Health Summit 2026 appeared first on KBC Digital .

More from Monday 17 August →